Laurus Labs lists with 14.50% premium on the bourses

19 Dec 2016 Evaluate

Laurus Labs debuted at Rs 490.00 on the BSE, up by 62 points or 14.49% from its issue price of Rs 428.

The scrip is currently trading at Rs 476.25, up by 48.25 points or 11.27% from its issue price. It has touched a high and low of Rs 498.00 and Rs 475.00 respectively. So far 19,17,000 shares were traded on the counter.

The offering, which was open for subscription between December 6 and December 8, was subscribed 4.52 times. The issue price was fixed at Rs 428 per share i.e. at upper end of price band of Rs 426-428 apiece.

Laurus Labs is a leading research and development driven pharmaceutical company in India. The company has grown consistently to become one of the leading manufacturers of Active Pharmaceutical Ingredients (APIs) for anti-retroviral (ARV) and Hepatitis C. Laurus Labs also manufactures APIs in oncology and other therapeutic areas.

Laurus Labs Share Price

1025.95 13.30 (1.31%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×